United States
Germany
Japan
United Kingdom
China
TP53 (Myc-DDK-tagged)-Human tumor protein p53 (TP53), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
TP53 mouse monoclonal antibody, clone OTI5E2 (formerly 5E2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse |
TP53 (untagged)-Human tumor protein p53 (TP53), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
p53 mouse monoclonal antibody,clone OTIpab 240
| Applications | IHC |
| Reactivities | Human |
Purified P53 (TP53) mouse monoclonal antibody, clone UMAB62
| Applications | 10k-ChIP, IF, IHC, WB |
| Reactivities | Human |
TP53 mouse monoclonal antibody, clone OTI3D5 (formerly 3D5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
TP53 mouse monoclonal antibody, clone OTI3A6 (formerly 3A6)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
TP53 (Myc-DDK-tagged)-Human tumor protein p53 (TP53), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
TP53 (Myc-DDK-tagged)-Human tumor protein p53 (TP53), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
TP53 mouse monoclonal antibody, clone OTI1D11 (formerly 1D11)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse |
Purified P53 (TP53) mouse monoclonal antibody, clone UMAB55
| Applications | IF, IHC, WB |
| Reactivities | Human |
TP53 (Myc-DDK-tagged)-Human tumor protein p53 (TP53), transcript variant 4
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
TP53 mouse monoclonal antibody, clone OTI2H6 (formerly 2H6)
| Applications | IF, IHC, WB |
| Reactivities | Human |
Purified P53 (TP53) mouse monoclonal antibody, clone UMAB18
| Applications | IHC, WB |
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Conjugates
Clonalities
Brands
QC Levels
Pathways
- Amyotrophic lateral sclerosis (ALS) (200)
- Apoptosis (200)
- Basal cell carcinoma (200)
- Bladder cancer (200)
- Cell cycle (200)
- Chronic myeloid leukemia (200)
- Colorectal cancer (200)
- Endometrial cancer (200)
- Glioma (200)
- Huntington's disease (200)
- MAPK signaling pathway (200)
- Melanoma (200)
- Neurotrophin signaling pathway (200)
- Non-small cell lung cancer (200)
- Pancreatic cancer (200)
- Pathways in cancer (200)
- Prostate cancer (200)
- Small cell lung cancer (200)
- Thyroid cancer (200)
- Wnt signaling pathway (200)
- p53 signaling pathway (200)
